Skip to main content

Gabelli Funds LLC

SEC CIK
0001081407
Latest filing
Aug 12, 2026

PTGX holding history

Protagonist Therapeutics, Inc in every 13F filed by Gabelli Funds LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PTGX overviewAll 13F holders of PTGXFull Q2 2026 holdings

Shares (Q2 2026)
2,900
Value
$355.5K
% of portfolio
<0.1%
Quarters held
2
Since Q1 2026
Holdings of PTGX by Gabelli Funds LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,900$355.5K<0.1%−329−10.2%ReducedHolders
Q1 20263,229$340.3K<0.1%+3,229NewHolders